Microbiology
Archaea
The third domain of life — ether-lipid membranes, no peptidoglycan, closer to you than to bacteria
Archaea are the third domain of life — single-celled prokaryotes that look like bacteria under a microscope but run on a fundamentally different chemistry. Their plasma membranes are built from ether-linked isoprenoid lipids on sn-glycerol-1-phosphate, the mirror image of the ester-linked fatty acids in every bacterium and eukaryote; their cell walls contain pseudomurein or S-layer proteins but never bacterial peptidoglycan; and their transcription and translation machinery is closer to yours than to a bacterium's. Carl Woese and George Fox defined the domain in 1977 by comparing 16S ribosomal RNA sequences, and the Asgard archaea discovered in 2015 are now the leading candidate for the ancestor of all eukaryotic life — including humans.
- Domain definedWoese & Fox, 1977
- Membraneether-linked isoprenoid lipids
- Cell wallno peptidoglycan
- Heat recordMethanopyrus at 122 °C
- Info machineryeukaryote-like
- Ocean plankton~20% are archaea
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
Why archaea matter
- They rewrote the tree of life. Before 1977 biology recognized two kinds of cell: prokaryote and eukaryote. Woese's ribosomal RNA data split the prokaryotes into two domains as deeply divergent as animals and plants, turning the tree of life from two trunks into three — Bacteria, Archaea, and Eukarya. It was one of the largest reclassifications in the history of biology.
- They may be our ancestors. Under the increasingly favored two-domain (eocyte) tree, eukaryotes are not a separate branch but a lineage nested inside the archaea. The host cell that engulfed the proto-mitochondrion — the founding event of complex life — was an archaeon, most likely an Asgard relative. Your ribosomes, histones, and RNA polymerase carry that archaeal inheritance.
- They run the methane cycle. Methanogens are the only organisms on Earth that produce biological methane, generating an estimated 1 billion tonnes per year from wetlands, rice paddies, landfills, termites, and the guts of ruminants. Methane is roughly 28 times more potent than CO₂ as a greenhouse gas over a century, so archaeal metabolism is a first-order lever on climate.
- They dominate the oceans and the nitrogen cycle. Marine Thaumarchaeota such as Nitrosopumilus maritimus oxidize ammonia to nitrite for a living and make up roughly 20% of all picoplankton cells in the sea — one of the most abundant cell types on the planet. They set the pace of oceanic nitrification and produce the greenhouse gas nitrous oxide.
- They gave biotech a workhorse enzyme. Thermostable DNA polymerases from hyperthermophilic archaea power modern molecular biology. Pfu polymerase from Pyrococcus furiosus has proofreading (3′→5′ exonuclease) activity and an error rate roughly tenfold lower than Taq, making it the enzyme of choice for high-fidelity PCR and cloning.
- They colonize the human body without making us sick. Methanobrevibacter smithii can account for up to 10% of anaerobes in the human colon, where it removes fermentation hydrogen and improves the efficiency of bacterial digestion. Yet no archaeon is a confirmed human pathogen — a puzzle that hints at how differently archaea and bacteria evolved.
How archaeal cells are built and run
An archaeon is a prokaryote — no nucleus, no membrane-bound organelles, typically 0.5 to a few micrometres across — but almost every molecular subsystem differs from the bacterial version. The defining feature is the membrane. Archaeal lipids join their hydrocarbon tails to glycerol through ether bonds rather than the ester bonds bacteria and eukaryotes use, and the tails themselves are branched isoprenoid chains (repeating five-carbon units) instead of straight fatty acids. Crucially, the glycerol backbone is sn-glycerol-1-phosphate, the exact stereochemical mirror image of the sn-glycerol-3-phosphate found in every other cell. This "lipid divide" is one of the strongest arguments that the two prokaryotic domains built their membranes independently. In hyperthermophiles two lipids fuse tail-to-tail into a tetraether that spans the entire membrane, converting the usual bilayer into a rigid, leak-proof monolayer.
The cell wall is the second hard boundary between the domains. Bacteria armor themselves with peptidoglycan (murein), a mesh of sugar chains cross-linked by peptides. Archaea never make it. Instead, methanogens like Methanobacterium use pseudomurein, which swaps N-acetylmuramic acid for N-acetyltalosaminuronic acid and uses β-1,3 linkages that lysozyme cannot cut; many other archaea rely on a paracrystalline S-layer of interlocking glycoproteins, or a sheath, or no wall at all. Because peptidoglycan synthesis is the target of penicillin and the substrate of lysozyme, archaea are intrinsically resistant to both.
The deepest surprise is in the information-processing machinery, which is unmistakably eukaryote-like. Archaeal RNA polymerase has 8 to 15 subunits homologous to the eukaryotic enzyme, not the streamlined 5-subunit bacterial core. Transcription starts with a TATA-binding protein (TBP) and transcription factor B (TFB), direct homologs of eukaryotic TBP and TFIIB. DNA replication uses a eukaryotic-type family-B DNA polymerase, an origin recognition complex (ORC/Cdc6), the MCM replicative helicase, and a PCNA sliding clamp. Many archaea package their genome with histone proteins that wrap DNA into nucleosome-like particles, and translation begins with a methionine (not the formyl-methionine bacteria use) delivered by a eukaryote-like set of initiation factors. In short, an archaeon has a bacterium's body plan and something like a eukaryote's software.
Metabolically archaea are extraordinarily versatile. Methanogens run a unique anaerobic pathway that reduces CO₂, acetate, or methyl compounds to methane using exotic coenzymes (coenzyme M, methanofuran, F420, and the nickel-tetrapyrrole F430) found nowhere else. Extreme halophiles like Halobacterium salinarum use the light-driven proton pump bacteriorhodopsin — a purple retinal protein — to make ATP, and pack their cytoplasm with molar concentrations of potassium chloride to balance the outside salt. Hyperthermophiles such as Pyrococcus and Sulfolobus respire on sulfur or hydrogen at temperatures that would denature almost any other protein.
Common misconceptions
- "Archaea are just weird bacteria." They are not a subgroup of bacteria — they are a separate domain, as distinct from bacteria as you are. The old name "archaebacteria" was retired in 1990 precisely because it implied a false relationship. Their membrane lipids, wall chemistry, and gene-expression machinery are all different.
- "All archaea live in extreme environments." The first-discovered archaea were extremophiles, so the reputation stuck, but molecular surveys since the 1990s show archaea are ordinary members of soil, freshwater, ocean, and gut communities. Marine ammonia-oxidizing Thaumarchaeota are among the most abundant cells on Earth and live in perfectly temperate seawater.
- "Archaea are primitive or ancient leftovers." The prefix archae- means "ancient," but archaea are not living fossils frozen in time. They are exactly as evolved as any bacterium or eukaryote, having accumulated the same billions of years of change since the last universal common ancestor.
- "Archaea and bacteria share the same membrane." They share the general architecture of a phospholipid barrier, but essentially none of the chemistry: ether vs ester bonds, isoprenoid vs fatty-acid tails, and opposite glycerol stereochemistry. The "lipid divide" is a defining molecular signature.
- "Because they cause no disease, archaea are irrelevant to human health." Gut methanogens shape digestion, hydrogen balance, and possibly conditions from constipation to obesity. Archaea are silent partners in the microbiome, not bystanders.
- "Antibiotics that kill bacteria kill archaea too." Many do not. Penicillins target peptidoglycan, which archaea lack; and because archaeal ribosomes and RNA polymerase resemble the eukaryotic versions, several ribosome- and transcription-targeting antibiotics that stop bacteria are ineffective against archaea.
Archaea vs Bacteria vs Eukarya
| Feature | Archaea | Bacteria | Eukarya |
|---|---|---|---|
| Nucleus | Absent | Absent | Present |
| Membrane lipid bond | Ether-linked | Ester-linked | Ester-linked |
| Lipid tails | Branched isoprenoid | Straight fatty acids | Straight fatty acids |
| Glycerol backbone | sn-glycerol-1-phosphate | sn-glycerol-3-phosphate | sn-glycerol-3-phosphate |
| Cell wall | Pseudomurein / S-layer (no peptidoglycan) | Peptidoglycan (murein) | None or cellulose/chitin |
| RNA polymerase | 8–15 subunits (eukaryote-like) | 5 subunits (core) | 3 polymerases, many subunits |
| Transcription factors | TBP + TFB | Sigma factors | TBP + TFIIB + many |
| DNA packaging | Histones (many taxa) | Nucleoid-associated proteins | Histones + nucleosomes |
| Translation start | Methionine | Formyl-methionine | Methionine |
| Methanogenesis | Only archaea | Never | Never |
| Penicillin sensitivity | Resistant | Sensitive | Not applicable |
The lipid divide, in detail
| Property | Archaeal membrane | Bacterial / eukaryotic membrane |
|---|---|---|
| Linkage to glycerol | Ether (C–O–C), hydrolysis-resistant | Ester (C–O–C=O), hydrolysis-prone |
| Hydrocarbon chains | Isoprenoid (phytanyl / biphytanyl) | Fatty acyl (palmitate, oleate, etc.) |
| Stereochemistry | sn-glycerol-1-phosphate (G1P) | sn-glycerol-3-phosphate (G3P) |
| Enzyme making backbone | G1P dehydrogenase (egsA) | G3P dehydrogenase |
| Membrane layer | Bilayer or spanning monolayer (tetraether) | Bilayer only |
| Advantage | Stable at high T, low pH, high salt | More fluid, cheaper to remodel |
| Extreme example | Pyrolobus fumarii grows at 113 °C | Few bacteria exceed ~95 °C |
A famous history: how a third domain was found
- Woese & Fox, 1977. Using 16S/18S ribosomal RNA oligonucleotide catalogues, Carl Woese and George Fox reported in PNAS that methanogens formed a group as distant from bacteria as from eukaryotes, and proposed a third "primary kingdom," the archaebacteria. The claim was so radical that much of the microbiology establishment resisted it for years.
- The lipid confirmation. Independent biochemistry soon backed the rRNA data: Thomas Langworthy, Morris Kates, and others showed that these organisms' membranes used ether-linked isoprenoid lipids on the "wrong" glycerol enantiomer — a chemistry no bacterium shares — turning a controversial sequence tree into a hard molecular boundary.
- The three-domain system, 1990. Woese, Otto Kandler, and Mark Wheelis formalized the framework in PNAS, renaming the groups Bacteria, Archaea, and Eukarya and elevating them above the rank of kingdom to domain. It remains the standard top-level classification of life.
- The eocyte tree, 1984 onward. James Lake argued from ribosome structure that eukaryotes branch specifically from within a group of sulfur-metabolizing archaea (the "eocytes," now Crenarchaeota/TACK). Decades of improved phylogenetics have increasingly favored this two-domain view over Woese's original symmetric three-domain tree.
- Asgard archaea, 2015–2020. Thijs Ettema's group recovered Lokiarchaeota genomes near the Loki's Castle vent in 2015, revealing eukaryotic signature proteins in an archaeon. In 2020 Hiroyuki Imachi's team cultured Prometheoarchaeum syntrophicum after over a decade of coaxing, imaging a cell with long branching protrusions — the closest living relative yet of the archaeal host that became the first eukaryote.
Frequently asked questions
What is the difference between archaea and bacteria?
Archaea and bacteria are both prokaryotes — small, single cells with no nucleus — but they diverged billions of years ago and differ at the level of core chemistry. Archaeal membrane lipids are ether-linked isoprenoid chains attached to sn-glycerol-1-phosphate; bacterial (and eukaryotic) lipids are ester-linked fatty acids on sn-glycerol-3-phosphate, the mirror-image stereochemistry. Archaea never make peptidoglycan (murein); their walls use pseudomurein, S-layer proteins, or nothing at all, which is why penicillin and lysozyme do not touch them. Their RNA polymerase has 8 to 15 subunits resembling the eukaryotic enzyme rather than the bacterial 5-subunit core, they use TATA-binding protein and TFB to start transcription, and many wrap their DNA around histone-like proteins. Woese first separated the two groups in 1977 by finding that their 16S ribosomal RNA sequences were as different from each other as either was from a human's.
How did Carl Woese discover archaea?
In the 1970s Carl Woese and his collaborator George Fox at the University of Illinois were using ribosomal RNA as a molecular clock. Because the small-subunit ribosomal RNA (16S in prokaryotes) is present in every cell and changes very slowly, its sequence records deep evolutionary history. Woese digested rRNA with a ribonuclease, separated the resulting oligonucleotide fragments by two-dimensional electrophoresis, and read off catalogues of short sequences. When he analyzed methanogens — anaerobes that make methane — their rRNA fingerprints matched neither typical bacteria nor eukaryotes. In a 1977 paper in the Proceedings of the National Academy of Sciences he proposed a third primary kingdom, the archaebacteria, and in 1990 he, Otto Kandler, and Mark Wheelis formalized the three-domain system: Bacteria, Archaea, and Eukarya.
Why are archaeal membranes made of ether lipids?
Ether bonds (C-O-C) are chemically far more stable than the ester bonds (C-O-C=O) that join fatty acids to glycerol in bacterial and eukaryotic membranes. Ester linkages hydrolyze readily at high temperature, low pH, and high salt — exactly the conditions many archaea live in. Archaeal lipids also use branched isoprenoid chains rather than straight fatty acids, and hyperthermophiles can fuse two lipids tail-to-tail into a single tetraether that spans the whole membrane, producing a rigid monolayer instead of a bilayer. These monolayers cannot flip apart, so a cell of Pyrolobus fumarii can hold its membrane together at 113 degrees Celsius and Picrophilus grows at pH 0. The lipids also attach to glycerol-1-phosphate, the opposite stereochemistry from every bacterium and eukaryote, one of the strongest pieces of evidence that the two prokaryotic membranes arose independently.
Are archaea more closely related to bacteria or to humans?
By cell shape and size archaea resemble bacteria, but by information-processing machinery they are closer to eukaryotes, which means they are closer to humans. Archaeal RNA polymerase, transcription factors (TBP and TFB), replication proteins (a eukaryotic-type DNA polymerase, ORC, MCM helicase, and PCNA sliding clamp), and translation initiation factors all have eukaryotic counterparts that bacteria lack. Many archaea also wrap DNA around histones. Molecular phylogenies increasingly place eukaryotes as a branch inside the archaea rather than as a separate sister group — the eocyte or two-domain tree. Under this model, first argued by James Lake in 1984 and strengthened by the discovery of Asgard archaea in 2015, the ancestor of all plants, animals, and fungi was itself an archaeon that acquired a bacterial endosymbiont, the future mitochondrion.
What are extremophiles and are all archaea extremophiles?
Extremophiles are organisms that thrive in physically or chemically extreme conditions — high temperature (thermophiles and hyperthermophiles above 80 degrees Celsius), high salt (halophiles at up to saturated 5 molar sodium chloride), low or high pH (acidophiles and alkaliphiles), and high pressure. Archaea hold most of the records: Methanopyrus kandleri strain 116 grows at 122 degrees Celsius, and Haloquadratum walsbyi packs Australian salt ponds. But it is a myth that all archaea are extremophiles. Since the 1990s, culture-independent surveys of ribosomal RNA have found archaea everywhere — Nitrosopumilus and other marine Thaumarchaeota make up roughly 20 percent of all ocean plankton cells and drive much of the nitrogen cycle, and methanogens live in soil, wetlands, cow rumens, and your own gut.
Do archaea cause disease?
No archaeon has ever been confirmed as a primary human pathogen — no archaeal equivalent of tuberculosis, cholera, or plague exists. This is striking given how abundant archaea are in and on the body. Methanogens such as Methanobrevibacter smithii are common members of the human gut microbiome, where they scavenge hydrogen produced by fermenting bacteria and vent it as methane, and Methanobrevibacter oralis lives in the mouth. Some researchers link these methanogens (sometimes called archaebiota) to conditions like periodontitis and constipation-predominant irritable bowel syndrome, but as ecological partners rather than direct invaders. Why archaea produce no classic pathogens is an open question — possibly they lack the virulence toolkits bacteria evolved, or their slow, energy-limited metabolism suits mutualism over invasion.
What are Asgard archaea and why do they matter?
Asgard archaea are a superphylum — named for Norse realms such as Loki, Thor, Odin, and Heimdall — first identified in 2015 from metagenomic sequences recovered near the Loki's Castle hydrothermal vent in the Arctic. Their genomes are riddled with eukaryotic signature proteins previously thought unique to complex cells: actin and profilin (a real cytoskeleton), a ubiquitin modification system, ESCRT membrane-remodeling machinery, and small GTPases. In 2020 a Japanese team led by Hiroyuki Imachi cultured the first Asgard archaeon, Prometheoarchaeum syntrophicum strain MK-D1, after twelve years of growth in the lab, and imaged its long protrusions. Asgard archaea are now the strongest evidence that eukaryotes, including humans, descend from within the archaeal domain — an archaeal host that engulfed a bacterium to become the first eukaryote.